本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Dianthus Therapeutics Inc.

21.56
-0.3100-1.42%
盤後21.560.00000.00%16:19 EDT
成交量:24.77萬
成交額:538.16萬
市值:6.93億
市盈率:-8.45
高:23.69
開:22.63
低:21.23
收:21.87
資料載入中...
2025/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/11

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2024/12/12

重要事件披露

Form 8-K - Current report
2024/12/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/22

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/07

SEC問詢函

Form CORRESP - Correspondence
2024/10/07

SEC問詢函

Form CORRESP - Correspondence
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/06

重要事件披露

Form 8-K - Current report